• Agenda
    • Programs
    • Plenary Keynotes
    • Speaker Biographies
    • Breakout Discussions
    • Who Attends
    • Archives
  • Sponsor/Exhibit
    • Attendee Demographics + Event Features
    • Current Sponsors
    • Sponsorship Opportunities
    • Exhibitor Prospectus
    • Current Exhibitors/Floorplan
    • Exhibitor Services/Schedule
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
  • Downloads
  • Travel
    • Travel Information
    • Health and Safety
  • Posters
    • Poster Information
    • Poster Titles
  • Press
  • Register
    • Individual Pricing
    • Group Pricing
    • On-Demand Pricing
Immuno Oncology Summit Europe

Archives


  • Immuno-Oncology Summit Europe- 18-22 March 2019

  • Immuno-Oncology Summit Europe- 19-23 March 2018

  • Immuno-Oncology Summit Europe- 20-24 March 2017

  • Cancer Biotherapeutics - 14-16 March 2016
Outlook YouTube Facebook LinkedIn Twitter
#IOSummitUK
Register Early for Maximum Savings
Final Agenda Now Available
Health and Safety
Targeting the Tumour Microenvironment
Immuno-Oncology Therapeutic Development
T-Cell Based Cancer Immunotherapy
Bi-specific and Multi-specific Antibody Therapeutics
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers

Request Information

Privacy Policy